Note: Ingredients listed on restricted chemical lists
EC/CAS
247-852-1/26628-22-8
Name of the chemical
Sodium Azide
Concentration
10-100% 0.09%
General Information
Revision date
2015-05-19
Product name
DRI T-Uptake Calibrators
Product Synonyms
0738 DRI® T-Uptake Calibrators
CAS No.
26628-22-8
1.2.1 Relevant identified uses
In vitro diagnostic kit
Emergency telephone
Canada
Icons in SDS
Company Information
company name
Microgenics Corporation
e-mail address of the competent person responsible for the Safety Data Sheet
techservice.mgc@thermofisher.com
GHS Information
Signal word
Warning
Section 2
2.1 Classification of the substance or mixture
Regulation (EC) Mixture not yet fully tested. 1272/2008 [GHS] Directive 67/548/EEC or Mixture not yet fully tested. 1999/45/EC
CLP CLASSIFICATION
None required None required
Signal word
Warning SECTION 2 - HAZARDS IDENTIFICATION …continued Caution US Hazard overview Mixture not yet fully tested. This product contains human source material and should be treated/handled as a potential biohazard. Note This product/mixture does not meet criteria for classification according to Directive 1999/45/EC and Regulation EC No 1272/2008 (EU CLP). Nevertheless, it should be regarded as hazardous as it is potentially biohazardous and the pharmacological, toxicological, and ecological properties of this mixture have not been fully characterized. The CLP/GHS classifications are based on Regulation (EC) 1272/2008 and on the revised OSHA hazard communication standard. The EU symbol/indicator of danger, R Phrases and Safety Advice are based on Directive 1999/45/EC.
Hazard statements
CLP/GHS precautionary None required EU symbol/indication of None required danger Risk (R) Phrase(s) None required
Precautionary statements
None required
2.3 Other hazards
The potential health hazards associated with exposure/handling of this mixture are unknown; no data specific for the mixture were identified. The following data describe the hazards of individual ingredients, where applicable. This product/mixture contains human source material (human serum) and should be treated/handled as a potential biohazard. All such human source material has been derived from donors tested individually and shown by FDA approved methods to be free from antibodies to Human Immune Deficiency Virus and Hepatitis B and C. As no test method can offer complete assurance that these or other infectious agents are not present, this product should be handled using standard biosafety precautions.